ArticleBritish journal of pharmacology2020

Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway.

Liwei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.